SCHEMBL8315465

SCHEMBL8315465

CC(C)(CO)CSc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C(=O)c5ccco5)CC4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.46
▸ JAK2 O60674 4/20 0.45
▸ CDK2 P24941 2/20 0.45
▸ CCNT1 O60563 1/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ CCNA1 P78396 1/20 0.45
▸ IKBKB O14920 3/20 0.44
▸ CHUK O15111 3/20 0.44
▸ IKBKG Q9Y6K9 3/20 0.44
▸ TSHR P16473 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ BTK Q06187 1/20 0.43
▸ MTOR P42345 1/20 0.43
▸ SMG1 Q96Q15 1/20 0.43
▸ JAK3 P52333 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308375 0.89 JAK2 (0.47) HTTJAK2CDK2IKBKBCHUK
SCHEMBL14063867 0.89 JAK2 (0.46) JAK2CDK2CDK9IKBKBCHUK
SCHEMBL14063857 0.88 IKBKB (0.49) HTTJAK2CDK2CCNT1CCNA2
SCHEMBL14021072 0.87 IKBKB (0.46) HTTJAK2CDK2IKBKBCHUK
SCHEMBL4070513 0.87 IKBKB (0.48) HTTJAK2CDK2IKBKBCHUK
SCHEMBL8315467 0.86 IKBKB (0.52) JAK2IKBKBCHUKIKBKGPLK4
SCHEMBL8308567 0.85 IKBKB (0.50) JAK2CDK2IKBKBCHUKIKBKG
SCHEMBL14021618 0.84 HTT (0.54) HTTJAK2CDK2IKBKBCHUK
SCHEMBL8313889 0.84 IKBKB (0.44) HTTJAK2CDK2CCNT1CCNA2
SCHEMBL8308468 0.84 SYK (0.47) JAK2CDK2IKBKBCHUKIKBKG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback